Vos
LATEST ISSUE

November/December 2024

For almost half a century, the principal measure of value in cost-effectiveness analysis has been the quality-adjusted life year (QALY). Several organizations have offered frameworks that include additional value dimensions not captured by the QALY.
VOL. 8, NO. 1

January/February 2022

Patient Advocacy: The Growing Voice of Healthcare
VOL. 7, NO. 6

November/December 2021

Finding the Best and Brightest: Getting a Leg Up on the Race for Talent
VOL. 7, NO. 5

September/October 2021

Wearables: Making a Mark in Digital Health
Vol. 7, No. S2

September 2021

Patients Versus Process: The Data and the Drivers Behind Patient-Centered Outcomes
VOL. 7, NO. 4

July/August 2021

The Benefits and Challenges of Aging in Place
VOL. 7, NO. 3

May/June 2021

Expanding the Value Conversation
VOL. 7, NO. 2

March/April 2021

Navigating the Changing HEOR Publishing Landscape
VOL. 7, NO. 2 S1

March 2021

Valuing Future Alzheimer's Disease Treatments: The Need for a Holistic Approach
VOL. 7, NO. 1

January/February 2021

Overcoming Vaccine Hesitancy: Injecting Trust in the Community
VOL. 6, NO. 6

November/December 2020

Challenges in Precision Medicine: Aiming to Align Data, Value, and Costs
VOL. 6, NO. 6 S2

November 2020 Supplement

November 2020 Supplement: Spotlight on Europe
Vol. 6 No. 5

September/October 2020

Unlocking the Promise of Real-World Evidence
VOL. 6, NO. 5 S1

September 2020 Supplement

September 2020 Supplement: Spotlight on Asia Pacific
VOL. 6 NO. 4

July/August 2020

Behavioral Economics: Examining Human Reactions To COVID-19
VOL. 6 , NO. 3

May/June 2020

Shared Risks, Shared Benefits: Innovative Pricing in Healthcare
VOL. 6 NO. 2

March/April 2020

COVID-19: A Global Crisis
VOL. 6 NO. 1

January/February 2020

The Digital Healthcare Ecosystem: Looking Outside to Harness From Within
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×